Related Experiment Video
Updated: May 27, 2026
06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
[Respect towards people with alzheimer's disease]
1Département d'ergothérapie, université du Québec, Trois-Rivières. marlene.falardeau@uqtr.ca
Soins. Gerontologie
|November 10, 2011
Summary
Respect is crucial for the quality of life and dignity of Alzheimer dementia (AD) residents. This study identifies how caregiver attitudes, environment, and activities demonstrate respect in care settings.
Area of Science:
- Gerontology
- Dementia Care
- Quality of Life Research
Context:
- Alzheimer dementia (AD) care settings
- Resident well-being and dignity
- Need for explicit definitions of respect in care
Purpose:
- To define concrete manifestations of respect in Alzheimer dementia (AD) care
- To explore how respect impacts resident quality of life and dignity
- To identify key elements contributing to a respectful care environment
Summary:
- Respect for Alzheimer dementia (AD) residents is demonstrated through caregiver attitudes, environmental factors, and organized activities.
- Caregiver behavior, the physical environment, and engagement in activities are key to upholding resident dignity.
- This study in Quebec, Canada, explicates the practical application of respect in dementia care.
Impact:
- Provides a framework for enhancing respectful care practices in Alzheimer dementia (AD) facilities.
- Informs caregiver training and environmental design to promote resident dignity.
- Contributes to improving the overall quality of life for individuals living with Alzheimer dementia (AD).
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...